Azacitidine and Lenalidomide (Combined vs Sequential Treatment) in Higher-Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study

Avanzini, Paolo; Barraco, Marilena; Bosi, Costanza; Candoni, Anna; Castagnari, Barbara; Cavo, Michele; Clissa, Cristina; Cocco, Lucio; Crugnola, Monica; Finelli, Carlo; Follo, Matilde; Gian Matteo Rigolin,; Giannini, Maria Benedetta; Gobbi, Marco; Leonardi, Giovanna; Mongiorgi, Sara; Parisi, Sarah; Russo, Domenico; Stanzani, Marta; Tosi, Patrizia; Visani, Giuseppe

Azacitidine and Lenalidomide (Combined vs Sequential Treatment) in Higher-Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study

Abstract

Azacitidine and Lenalidomide (Combined vs Sequential Treatment) in Higher-Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Stud

Similar works

Full text

Available Versions

Archivio istituzionale della ricerca - Università di Ferrara

oai:iris.unife.it:11392/236425...

Last time updated on 13/04/2017